Aptorum Group Limited to Present at the H.C. Wainwright Global Investment Conference, May 23 – 26 2022
17.05.2022 - Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that Mr. Darren ...
Aptorum Group Form Daptorum Group Technologies Pte Ltd Aptorum Group Limited Nasdaq Singapore Agency For Science About Aptorum
Source: wallstreet-online.de